Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

DS-8201a Shows Promise in Treatment of HER2-Positive Breast Cancer

Sherene Loi, MD, PhD, Consultant Medical Oncologist, Peter MacCallum Cancer Centre, Melbourne, Australia, spoke with Oncology Learning Network about data that was presented regarding the use of DS-8201a in the treatment of HER2-positive breast cancer.

 

Advertisement

Advertisement

Advertisement

Advertisement